# Keros Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/keros-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 38 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-20T04:46:48.195962+00:00 |
| Last reviewed | 2026-10-20T04:46:48.195962+00:00 |

## Identity

- Legal name: Keros Therapeutics, Inc.
- Display name: Keros Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-20T09:21:38.384911+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.824 |
| Directors | 9 |
| Committees | 4 |
| Governance events | 6 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Alpna Seth: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:6
- Julius Knowles: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:9
- Mary Ann Gray: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:10
- Nima Farzan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:11
- Ran Nussbaum: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:12
- Tomer Kariv: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:13
- Charles Newton: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:7
- Jasbir Seehra: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:8
- Jean-Jacques Bienaimé: Chair of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:5

## Committees

- Audit Committee (audit). Chair: NOT_PUBLISHED. Members: Alpna Seth (member, current); Julius Knowles (member, current); Mary Ann Gray (member, current); Nima Farzan (member, current); Ran Nussbaum (member, current); Tomer Kariv (member, current). committee_id=alpha:committee:keros-therapeutics-inc:audit-committee
- Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Jasbir Seehra (member, unknown). committee_id=alpha:committee:keros-therapeutics-inc:chief-executive-officer-and-director
- Compensation Committee (compensation). Chair: NOT_PUBLISHED. Members: Alpna Seth (member, current); Julius Knowles (member, current); Mary Ann Gray (member, current); Nima Farzan (member, current); Ran Nussbaum (member, current); Tomer Kariv (member, current). committee_id=alpha:committee:keros-therapeutics-inc:compensation-committee
- Nominating and Corporate Governance Committee (nominating_governance). Chair: NOT_PUBLISHED. Members: Alpna Seth (member, current); Julius Knowles (member, current); Mary Ann Gray (member, current); Nima Farzan (member, current); Ran Nussbaum (member, current); Tomer Kariv (member, current). committee_id=alpha:committee:keros-therapeutics-inc:nominating-and-corporate-governance-committee

## Executive leadership

- Esther Cho: Chief Legal Officer and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:14
- Jasbir Seehra: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:15
- Keith Regnante: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:16
- Lorena Lerner: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:17

## Governance events

- DIRECTOR_APPOINTED: Ran Nussbaum seat on Keros Therapeutics, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-20T04:46:48.195962+00:00. event_id=alpha:event:transition:1fgzkwt1jkeo1x
- DIRECTOR_APPOINTED: Tomer Kariv seat on Keros Therapeutics, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-20T04:46:48.195962+00:00. event_id=alpha:event:transition:1l4td0m11xgsow
- DIRECTOR_APPOINTED: Alpna Seth seat on Keros Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-20T04:46:48.195962+00:00. event_id=alpha:event:transition:1vujbblwc7nj5
- DIRECTOR_APPOINTED: Mary Ann Gray seat on Keros Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-20T04:46:48.195962+00:00. event_id=alpha:event:transition:12hhsn129705t
- DIRECTOR_APPOINTED: Nima Farzan seat on Keros Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-20T04:46:48.195962+00:00. event_id=alpha:event:transition:tmukb41r4po4k
- DIRECTOR_APPOINTED: Julius Knowles seat on Keros Therapeutics, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-20T04:46:48.195962+00:00. event_id=alpha:event:transition:9mekiq123dmqk

## Scoped resources

- `alpha://company/keros-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record
- `alpha://company/keros-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=identity
- `alpha://company/keros-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/keros-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=board
- `alpha://company/keros-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=committees
- `alpha://company/keros-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=leadership
- `alpha://company/keros-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=ownership
- `alpha://company/keros-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=financials
- `alpha://company/keros-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/keros-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=compensation
- `alpha://company/keros-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=governance
- `alpha://company/keros-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/keros-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=audit
- `alpha://company/keros-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=legal
- `alpha://company/keros-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=risk
- `alpha://company/keros-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=cyber
- `alpha://company/keros-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/keros-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=agents
- `alpha://company/keros-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/keros-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=events
- `alpha://company/keros-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=relationships
- `alpha://company/keros-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=assessments
- `alpha://company/keros-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:alpna-seth-kros","name":"Alpna Seth"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:julius-knowles-kros","name":"Julius Knowles"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mary-ann-gray-kros","name":"Mary Ann Gray"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:nima-farzan-kros","name":"Nima Farzan"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ran-nussbaum-kros","name":"Ran Nussbaum"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:tomer-kariv-kros","name":"Tomer Kariv"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:alpna-seth-kros","name":"Alpna Seth"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:julius-knowles-kros","name":"Julius Knowles"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:mary-ann-gray-kros","name":"Mary Ann Gray"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:nima-farzan-kros","name":"Nima Farzan"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:ran-nussbaum-kros","name":"Ran Nussbaum"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:tomer-kariv-kros","name":"Tomer Kariv"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:alpna-seth-kros","name":"Alpna Seth"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:julius-knowles-kros","name":"Julius Knowles"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:mary-ann-gray-kros","name":"Mary Ann Gray"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:36: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:nima-farzan-kros","name":"Nima Farzan"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:37: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:ran-nussbaum-kros","name":"Ran Nussbaum"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:tomer-kariv-kros","name":"Tomer Kariv"},"source_id":"governance_people_committees"}`

## Leadership

- Jean-Jacques Bienaimé: Chair of the Board. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20.
- Alpna Seth: Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:138d82fd43d3f17af4ae7b2be22ced0e7fb816762d7fd79d33d39987454bf025.
- Charles Newton: Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20.
- Jasbir Seehra: President, Chief Executive Officer and Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20.
- Julius Knowles: Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:9. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:138d82fd43d3f17af4ae7b2be22ced0e7fb816762d7fd79d33d39987454bf025.
- Mary Ann Gray: Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:138d82fd43d3f17af4ae7b2be22ced0e7fb816762d7fd79d33d39987454bf025.
- Nima Farzan: Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:11. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:138d82fd43d3f17af4ae7b2be22ced0e7fb816762d7fd79d33d39987454bf025.
- Ran Nussbaum: Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:12. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:138d82fd43d3f17af4ae7b2be22ced0e7fb816762d7fd79d33d39987454bf025.
- Tomer Kariv: Director. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:13. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:138d82fd43d3f17af4ae7b2be22ced0e7fb816762d7fd79d33d39987454bf025.
- Esther Cho: Chief Legal Officer and Secretary. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20.
- Jasbir Seehra: President and Chief Executive Officer. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20.
- Keith Regnante: Chief Financial Officer. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20.
- Lorena Lerner: Chief Scientific Officer. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit Committee: Chair not stated; Members Alpna Seth; Julius Knowles; Mary Ann Gray; Nima Farzan; Ran Nussbaum; Tomer Kariv. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Compensation Committee: Chair not stated; Members Alpna Seth; Julius Knowles; Mary Ann Gray; Nima Farzan; Ran Nussbaum; Tomer Kariv. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Nominating and Corporate Governance Committee: Chair not stated; Members Alpna Seth; Julius Knowles; Mary Ann Gray; Nima Farzan; Ran Nussbaum; Tomer Kariv. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_record:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Keros Therapeutics, Inc.. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5dbcb05a0c7902e7bd18883f455ef70e67d9e1055d1be961dc797786ccf1fd8e.

## Entity Status

- Public listing published. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5dbcb05a0c7902e7bd18883f455ef70e67d9e1055d1be961dc797786ccf1fd8e.

## Published Fact

- US. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5dbcb05a0c7902e7bd18883f455ef70e67d9e1055d1be961dc797786ccf1fd8e.

## Committee Appointment

- Alpna Seth: member, Audit Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Julius Knowles: member, Audit Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Mary Ann Gray: member, Audit Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Nima Farzan: member, Audit Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Ran Nussbaum: member, Audit Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Tomer Kariv: member, Audit Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Alpna Seth: member, Compensation Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Julius Knowles: member, Compensation Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Mary Ann Gray: member, Compensation Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Nima Farzan: member, Compensation Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Ran Nussbaum: member, Compensation Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Tomer Kariv: member, Compensation Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Alpna Seth: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Julius Knowles: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Mary Ann Gray: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Nima Farzan: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Ran Nussbaum: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.
- Tomer Kariv: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c.

## Security Listing

- KROS (NASDAQ). Claim: alpha:claim:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1:security_listing:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5dbcb05a0c7902e7bd18883f455ef70e67d9e1055d1be961dc797786ccf1fd8e.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:5dbcb05a0c7902e7bd18883f455ef70e67d9e1055d1be961dc797786ccf1fd8e: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/keros-therapeutics-inc).
- alpha:projection-evidence:document:6d7958636fad289fc9c53943dfb27400440e653bb76b8eabb47e3b9276605a20: [SEC DEF 14A 0001104659-26-046791](https://www.sec.gov/Archives/edgar/data/1664710/000110465926046791/tm261345-1_def14a.htm).
- alpha:projection-evidence:document:138d82fd43d3f17af4ae7b2be22ced0e7fb816762d7fd79d33d39987454bf025: [DEF 14A tm261345-1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1664710/000110465926046791/tm261345-1_def14a.htm).
- alpha:projection-evidence:720895c3dba519c7ccee6196a7dac71f252c01d9860caf436f5669abf9df743c: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1664710/000110465926046791/tm261345-1_def14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/keros-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/keros-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/keros-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/keros-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-20T09:21:38.164778+00:00; recorded 2026-10-20T09:21:38.164778+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.